Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Zelira Therapeutics Questions & Anwsers

Q: What sector and industry does Zelira Therapeutics (ZLDAF) operate in?

Zelira Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the OTC.

How do I buy Zelira Therapeutics (ZLDAF) stock?

You can purchase shares of Zelira Therapeutics (OTC: ZLDAF) through any online brokerage.

View our list of the best stock brokerages.

Who are Zelira Therapeutics's (ZLDAF) competitors?

There are no as such competitors for Zelira Therapeutics.

What is the target price for Zelira Therapeutics (ZLDAF) stock?

There is no analysis for Zelira Therapeutics

Current Stock Price for Zelira Therapeutics (ZLDAF)?

The stock price for Zelira Therapeutics (OTC: ZLDAF) is $0.028 last updated Wed Oct 27 2021 14:51:05 GMT+0000 (Coordinated Universal Time).

Does Zelira Therapeutics (ZLDAF) pay a dividend?

There are no upcoming dividends for Zelira Therapeutics.

When is Zelira Therapeutics (OTC:ZLDAF) reporting earnings?

Zelira Therapeutics does not have any upcoming earnings scheduled.

Is Zelira Therapeutics (ZLDAF) going to split?

There is no upcoming split for Zelira Therapeutics.

What sector and industry does Zelira Therapeutics (ZLDAF) operate in?

Zelira Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the OTC.

QQQ

DIA

SPY

TLT

GLD

BTC/USD

QQQ

DIA

SPY

TLT

GLD